Silence Therapeutics PLC (SLN)
13.98
-1.30
(-8.54%)
USD |
NASDAQ |
Nov 14, 16:00
13.98
0.00 (0.00%)
After-Hours: 20:00
Silence Therapeutics Total Liabilities (Quarterly): 96.29M for June 30, 2024
Total Liabilities (Quarterly) Chart
Historical Total Liabilities (Quarterly) Data
| Date | Value |
|---|---|
| June 30, 2024 | 96.29M |
| March 31, 2024 | 88.98M |
| December 31, 2023 | 97.80M |
| September 30, 2023 | 95.10M |
| June 30, 2023 | 101.48M |
| March 31, 2023 | 96.29M |
| December 31, 2022 | 103.38M |
| September 30, 2022 | 100.40M |
| June 30, 2022 | 106.91M |
| March 31, 2022 | 108.76M |
| December 31, 2021 | 118.32M |
| September 30, 2021 | 102.58M |
| June 30, 2021 | 106.65M |
| June 30, 2021 | 106.65M |
| December 31, 2020 | 104.82M |
| June 30, 2020 | 89.19M |
| June 30, 2020 | 89.19M |
| December 31, 2019 | 33.00M |
| June 30, 2019 | 3.623M |
| June 30, 2019 | 3.623M |
| December 31, 2018 | 4.860M |
| June 30, 2018 | 4.710M |
| June 30, 2018 | 4.710M |
| December 31, 2017 | 3.591M |
| June 30, 2017 | 3.601M |
| Date | Value |
|---|---|
| June 30, 2017 | 3.601M |
| December 31, 2016 | 1.978M |
| June 30, 2016 | 2.046M |
| June 30, 2016 | 2.046M |
| December 31, 2015 | 1.656M |
| June 30, 2015 | 1.456M |
| June 30, 2015 | 1.456M |
| December 31, 2014 | 3.133M |
| June 30, 2014 | 2.601M |
| June 30, 2014 | 2.601M |
| December 31, 2013 | 2.843M |
| June 30, 2013 | 1.420M |
| June 30, 2013 | 1.420M |
| December 31, 2012 | 1.550M |
| June 30, 2012 | 1.522M |
| June 30, 2012 | 1.522M |
| December 31, 2011 | 1.941M |
| June 30, 2011 | 3.332M |
| December 31, 2010 | 2.602M |
| June 30, 2010 | 4.109M |
| December 31, 2009 | 3.401M |
| June 30, 2009 | 1.363M |
| December 31, 2008 | 1.370M |
| June 30, 2008 | 1.566M |
| December 31, 2007 | 3.579M |
Total Liabilities Definition
Liabilities are a main portion of the balance sheet of a company that measure outstanding payables/obligations. A few examples of liabilties of a company include accounts payable, current debt, and capital lease obligations. From an accounting perspective, the balance sheet equation is Liabilties = Assets - Shareholder's Equity.
Total Liabilities (Quarterly) Range, Past 5 Years
33.00M
Minimum
Dec 2019
118.32M
Maximum
Dec 2021
96.99M
Average
100.94M
Median
Total Liabilities (Quarterly) Benchmarks
| NuCana PLC | 20.58M |
| TC BioPharm (Holdings) PLC | 7.807M |
| Biodexa Pharmaceuticals PLC | 6.628M |
| Adaptimmune Therapeutics PLC | 225.43M |
| Verona Pharma PLC | 251.33M |
Total Liabilities (Quarterly) Related Metrics
| Total Assets (Quarterly) | 238.59M |
| Shareholders Equity (Quarterly) | 142.30M |
| Current Ratio | 9.830 |